These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 28980185)
1. Development of a New Aprepitant Liquisolid Formulation with the Aid of Artificial Neural Networks and Genetic Programming. Barmpalexis P; Grypioti A; Eleftheriadis GK; Fatouros DG AAPS PharmSciTech; 2018 Feb; 19(2):741-752. PubMed ID: 28980185 [TBL] [Abstract][Full Text] [Related]
2. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine). Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of ketoconazole dissolution rate by the liquisolid technique. Molaei MA; Osouli-Bostanabad K; Adibkia K; Shokri J; Asnaashari S; Javadzadeh Y Acta Pharm; 2018 Sep; 68(3):325-336. PubMed ID: 31259692 [TBL] [Abstract][Full Text] [Related]
4. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique. Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of ketoprofen dissolution rate by the liquisolid technique: optimization and in vitro and in vivo investigations. Devi S; Kumar S; Verma V; Kaushik D; Verma R; Bhatia M Drug Deliv Transl Res; 2022 Nov; 12(11):2693-2707. PubMed ID: 35178670 [TBL] [Abstract][Full Text] [Related]
6. Formulation Development of Mirtazapine Liquisolid Compacts: Optimization Using Central Composite Design. Naureen F; Shah Y; Shah SI; Abbas M; Rehman IU; Muhammad S; Hamdullah H; Goh KW; Khuda F; Khan A; Chan SY; Mushtaq M; Ming LC Molecules; 2022 Jun; 27(13):. PubMed ID: 35807252 [TBL] [Abstract][Full Text] [Related]
7. Effects of liquisolid formulations on dissolution of naproxen. Tiong N; Elkordy AA Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184 [TBL] [Abstract][Full Text] [Related]
8. Preparation of Curcuma comosa tablets using liquisolid techniques: In vitro and in vivo evaluation. Jaipakdee N; Limpongsa E; Sripanidkulchai BO; Piyachaturawat P Int J Pharm; 2018 Dec; 553(1-2):157-168. PubMed ID: 30316793 [TBL] [Abstract][Full Text] [Related]
9. Spironolactone release from liquisolid formulations prepared with Capryol™ 90, Solutol® HS-15 and Kollicoat® SR 30 D as non-volatile liquid vehicles. Elkordy AA; Tan XN; Essa EA Eur J Pharm Biopharm; 2013 Feb; 83(2):203-23. PubMed ID: 22960707 [TBL] [Abstract][Full Text] [Related]
10. Characterization and Pharmacokinetic Study of Aprepitant Solid Dispersions with Soluplus®. Liu J; Zou M; Piao H; Liu Y; Tang B; Gao Y; Ma N; Cheng G Molecules; 2015 Jun; 20(6):11345-56. PubMed ID: 26102068 [TBL] [Abstract][Full Text] [Related]
11. Dissolution enhancement of tadalafil by liquisolid technique. Lu M; Xing H; Yang T; Yu J; Yang Z; Sun Y; Ding P Pharm Dev Technol; 2017 Feb; 22(1):77-89. PubMed ID: 27268461 [TBL] [Abstract][Full Text] [Related]
12. Solid microcrystalline dispersion films as a new strategy to improve the dissolution rate of poorly water soluble drugs: A case study using olanzapine. Modica de Mohac L; de Fátima Pina M; Raimi-Abraham BT Int J Pharm; 2016 Jul; 508(1-2):42-50. PubMed ID: 27154255 [TBL] [Abstract][Full Text] [Related]
13. Effect of Ceolus KG-802 on the dissolution rate of fenofibrate liquisolid tablets: Preformulation and formulation development studies. Karmarkar AB Drug Discov Ther; 2010 Dec; 4(6):493-8. PubMed ID: 22491315 [TBL] [Abstract][Full Text] [Related]
14. Formulation factors affecting the release of ezetimibe from different liquisolid compacts. Khanfar M; Sheikh Salem M; Hawari R Pharm Dev Technol; 2013; 18(2):417-27. PubMed ID: 22530561 [TBL] [Abstract][Full Text] [Related]
15. [Liquisolid technique for enhancement of dissolution prosperities of tanshinone II(A)]. Liu XQ; Meng QJ; Xu XL; Zhao J; Yang H; Yi H Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4840-6. PubMed ID: 27245032 [TBL] [Abstract][Full Text] [Related]
16. The Combined Use of Imaging Approaches to Assess Drug Release from Multicomponent Solid Dispersions. Punčochová K; Ewing AV; Gajdošová M; Pekárek T; Beránek J; Kazarian SG; Štěpánek F Pharm Res; 2017 May; 34(5):990-1001. PubMed ID: 27573574 [TBL] [Abstract][Full Text] [Related]
17. Solid dispersions in the development of a nimodipine floating tablet formulation and optimization by artificial neural networks and genetic programming. Barmpalexis P; Kachrimanis K; Georgarakis E Eur J Pharm Biopharm; 2011 Jan; 77(1):122-31. PubMed ID: 20934511 [TBL] [Abstract][Full Text] [Related]
18. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties. Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116 [TBL] [Abstract][Full Text] [Related]
19. Formulation of fenofibrate liquisolid tablets using central composite design. Patel T; Patel LD; Suhagia BN; Soni T; Patel T Curr Drug Deliv; 2014; 11(1):11-23. PubMed ID: 24712439 [TBL] [Abstract][Full Text] [Related]
20. Preparation of sustained-release dosage form of Venlafaxine HCl using liquisolid technique. Khanfar M; Sheikh Salem M; Kaddour F Pharm Dev Technol; 2014 Feb; 19(1):103-15. PubMed ID: 23347382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]